JaniceFayeOlsonMDMHA

Pediatric Hematology & Oncology • Portland, OR

Childrens Cancer and Blood Disorders Program at Randall Childrens Hospital

Join to view full profile

Dr. Olson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Olson's full profile

Already have an account?

Office
2801 N Gantenbein
Third Floor
Portland, OR 97227
Phone+1 503-276-9300

Fax+1 503-276-9351
Is this information wrong?

Summary

Medical Director of Childrens Cancer and Blood Disorders Program

Education & Training

UNC-Chapel HillMHA, Health Policy and Administration, 1995 - 1997
Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1991 - 1992
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1988 - 1991
Baylor College of Medicine (Houston)Residency, Pediatrics, 1986 - 1988
Baylor College of Medicine (Houston)Internship, Pediatrics, 1985 - 1986
University of Utah School of MedicineClass of 1985

Certifications & Licensure

OR State Medical License 1999 - 2025
NC State Medical License 1991 - 1999
TX State Medical License 1986 - 1992
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2011-2014
America's Top Doctors for Cancer Castle Connolly, 2013
Portland Monthly Magazine Castle Connolly, 2011
Top Docs Portland Monthly, 2009-2011
Join now to see all

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
Recruiting
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01
Completed
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Start of enrollment: 2011 May 01
Completed
Not Applicable
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
Active, not recruiting
Phase 3
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Start of enrollment: 2012 Jun 27
Active, not recruiting
Phase 2
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Start of enrollment: 2013 Nov 04
Completed
Phase 3
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

36 citations
Measuring the Effects of an Animal-Assisted Intervention for Pediatric Oncology Patients and Their Parents: A Multisite Randomized Controlled Trial [Formula: see text].
Amy McCullough, Ashleigh Ruehrdanz, Molly Jenkins, Mary Jo Gilmer, Janice Olson, Anjali S Pawar, Leslie Holley, Shirley Sierra-Rivera, Deborah E. Linder, Danielle Pich...> ;Journal of Pediatric Oncology Nursing. 2018 May 1
17 citations
Pregnant women's perspectives on umbilical cord blood banking.
Jeremy Sugarman, Lyla Kaplan, Betty E. Cogswell, Janice Olson> ;Journal of Women's Health. 1998 Aug 1
8 citations
Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute ly...
Michael L. Graham, Barbara L. Asselin, James E. Herndon, J. R. Casey, Sara Chaffee, G. Ciocci, Charles Daeschner, A. R. Davis, Stuart H. Gold, Edward C. Halperin, Mary...> ;Bone Marrow Transplantation. 1998 May 1
62 citations
Gastric graft-versus-host disease: A blinded histologic study
Kay Washington, Rex C. Bentley, Annette M. Green, Janice Olson, William R. Treem, Hannah R. Krigman> ;The American Journal of Surgical Pathology. 1997 Sep 1
131 citations
High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.
Michael L. Graham, James E. Herndon, J. R. Casey, Sara Chaffee, G. Ciocci, Jeffrey P. Krischer, Joanne Kurtzberg, Mary J. Laughlin, Darryl C. Longee, Janice F. Olson, ...> ;Journal of Clinical Oncology. 1997 May 1
726 citations
Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated Recipients.
Joanne Kurtzberg, Mary J. Laughlin, Michael L. Graham, Clay Smith, Janice F. Olson, Edward C. Halperin, G. Ciocci, Carmelita Carrier, Cladd E. Stevens, Pablo Rubinstein> ;The New England Journal of Medicine. 1996 Jul 18
14 citations
Treatment of patients with pineoblastoma with high dose cyclophosphamide
David M. Ashley, Darryl C. Longee, Robert D. Tien, Herbert E. Fuchs, Michael L. Graham, Joanne Kurtzberg, J. R. Casey, Janice F. Olson, Lisa Meier, Linda D. Ferrell, T...> ;Medical and Pediatric Oncology. 1996 Jun 1
8 citations
Hemoglobin C disease in infancy and childhood
Janice Olson, Russell E. Ware, William H. Schultz, Thomas R. Kinney> ;The Journal of Pediatrics. 1994 Nov 1
67 citations
The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation.
Joanne Kurtzberg, M. Graham, J. R. Casey, Janice F. Olson, Cladd E. Stevens, P. Rubinstein> ;Blood Cells. 1994 Jan 1
Join now to see all